Logo image of TELO.CA

TELO GENOMICS CORP (TELO.CA) Stock Overview

Canada - TSX-V:TELO - CA87975M2085 - Common Stock

0.07 CAD
0 (-6.67%)
Last: 9/12/2025, 7:00:00 PM

TELO.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High0.23
52 Week Low0.07
Market Cap7.03M
Shares100.43M
Float96.38M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.03
PEN/A
Fwd PEN/A
Earnings (Next)10-23 2025-10-23
IPO02-15 2012-02-15
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


TELO.CA short term performance overview.The bars show the price performance of TELO.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

TELO.CA long term performance overview.The bars show the price performance of TELO.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TELO.CA is 0.07 CAD. In the past month the price decreased by -6.67%. In the past year, price decreased by -69.57%.

TELO GENOMICS CORP / TELO Daily stock chart

TELO.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EDT.CA SPECTRAL MEDICAL INC N/A 485.89M
FRX.CA FENNEC PHARMACEUTICALS INC N/A 355.67M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 264.31M
TH.CA THERATECHNOLOGIES INC N/A 210.13M
HBP.CA HELIX BIOPHARMA CORP N/A 116.10M
WLLW.CA WILLOW BIOSCIENCES INC N/A 100.71M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 88.41M
BLU.CA BLUENERGIES LTD N/A 82.42M
NRX.CA NUREXONE BIOLOGIC INC N/A 72.01M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 67.23M
COV.CA COVALON TECHNOLOGIES LTD 16.92 60.32M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 47.21M

About TELO.CA

Company Profile

TELO logo image Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.

Company Info

TELO GENOMICS CORP

Mars Centre, 101 College St Suite 200

TORONTO ONTARIO M5G 1L7 CA

CEO: Sherif Louis

Employees: 0

TELO Company Website

TELO Investor Relations

Phone: 14166738487

TELO GENOMICS CORP / TELO.CA FAQ

What is the stock price of TELO GENOMICS CORP today?

The current stock price of TELO.CA is 0.07 CAD. The price decreased by -6.67% in the last trading session.


What is the ticker symbol for TELO GENOMICS CORP stock?

The exchange symbol of TELO GENOMICS CORP is TELO and it is listed on the TSX Venture Exchange exchange.


On which exchange is TELO.CA stock listed?

TELO.CA stock is listed on the TSX Venture Exchange exchange.


What is TELO GENOMICS CORP worth?

TELO GENOMICS CORP (TELO.CA) has a market capitalization of 7.03M CAD. This makes TELO.CA a Nano Cap stock.


How many employees does TELO GENOMICS CORP have?

TELO GENOMICS CORP (TELO.CA) currently has 0 employees.


What are the support and resistance levels for TELO GENOMICS CORP (TELO.CA) stock?

TELO GENOMICS CORP (TELO.CA) has a resistance level at 0.08. Check the full technical report for a detailed analysis of TELO.CA support and resistance levels.


Should I buy TELO GENOMICS CORP (TELO.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TELO GENOMICS CORP (TELO.CA) stock pay dividends?

TELO.CA does not pay a dividend.


When does TELO GENOMICS CORP (TELO.CA) report earnings?

TELO GENOMICS CORP (TELO.CA) will report earnings on 2025-10-23.


What is the Price/Earnings (PE) ratio of TELO GENOMICS CORP (TELO.CA)?

TELO GENOMICS CORP (TELO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).


TELO.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TELO.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TELO.CA. While TELO.CA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TELO.CA Financial Highlights

Over the last trailing twelve months TELO.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 25.81% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -186.84%
ROE -232.51%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%1.18%
Sales Q2Q%N/A
EPS 1Y (TTM)25.81%
Revenue 1Y (TTM)N/A

TELO.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

TELO.CA Ownership

Ownership
Inst Owners2.06%
Ins Owners4.05%
Short Float %N/A
Short RatioN/A